Chinmedomics Strategy for Elucidating the Pharmacological Effects and Discovering Bioactive Compounds From Keluoxin Against Diabetic Retinopathy

• Asıl Yazarlar: Ling Kong (Yazar), Ye Sun (Yazar), Hui Sun (Yazar), Ai-hua Zhang (Yazar), Bo Zhang (Yazar), Nan Ge (Yazar), Xi-jun Wang (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Frontiers Media S.A., 2022-03-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Keluoxin (KLX) is an active agent in the treatment of diabetic retinopathy (DR). However, its mechanism, targets, and effective constituents against DR are still unclear, which seriously restricts its clinical application. Chinmedomics has the promise of explaining the pharmacological effects of her...